Search research articles
Contact Us
Filters
Showing results (131-140 of 237) with videos related to
Page
of 24
Sort By:
Gynecologic Oncology
|
September 8, 2023
Differential outcomes and immune checkpoint inhibitor response among endometrial cancer patients with MLH1 hypermethylation versus MLH1 "Lynch-like" mismatch repair gene mutation
Michael D Toboni, Sharon Wu, Alex Farrell, et al.
Gynecologic Oncology
|
May 25, 2021
Uterine carcinosarcomas: From pathology to practice
Michael D Toboni, Erin K Crane, Jubilee Brown, et al.
Gynecologic Oncology
|
April 1, 2023
HER2+ endometrioid endometrial cancer possesses distinct molecular and immunologic features associated with a more active immune microenvironment and worse prognosis
Shaina F Bruce, Sharon Wu, Jennifer R Ribeiro, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
June 13, 2020
Long-term outcomes of intensity-modulated radiation therapy (IMRT) and high dose rate brachytherapy as adjuvant therapy after radical hysterectomy for cervical cancer
Jessika Contreras, Amar Srivastava, Anupama Chundury, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
April 14, 2025
Accuracy of surveillance serum squamous cell carcinoma antigen for cervical cancer recurrence after definitive chemoradiation
Victoria Shi, Surbhi Grover, Yi Huang, et al.
Obstetrics and Gynecology
|
March 15, 2019
Wound Complication Rates After Vulvar Excisions for Premalignant Lesions
Mary M Mullen, Emily C Merfeld, Marguerite L Palisoul, et al.
Gynecologic Oncology
|
September 5, 2012
A phase I study with an expanded cohort to assess feasibility of intravenous docetaxel, intraperitoneal carboplatin and intraperitoneal paclitaxel in patients with previously untreated ovarian, fallopian tube or primary peritoneal carcinoma: a Gynecologic Oncology Group study
Natalie Gould, Michael W Sill, Robert S Mannel, et al.
Brain, Behavior, and Immunity
|
February 16, 2023
Propranolol reduces IFN-γ driven PD-L1 immunosuppression and improves anti-tumour immunity in ovarian cancer
M Falcinelli, G Al-Hity, S Baron, et al.
Gynecologic Oncology
|
June 22, 2014
A phase II trial of a surgical protocol to decrease the incidence of wound complications in obese gynecologic oncology patients
Akiva P Novetsky, Israel Zighelboim, Saketh R Guntupalli, et al.
Gynecologic Oncology Reports
|
August 31, 2019
Patients with endometrial cancer continue to lack understanding of their risks for cancer
Subhjit Sekhon, L Stewart Massad, Andrea R Hagemann, et al.
Page
of 24
Search research articles
Search
Showing results (131-140 of 237) with videos related to
Sort By:
Page
of 24
Gynecologic Oncology
|
September 8, 2023
Differential outcomes and immune checkpoint inhibitor response among endometrial cancer patients with MLH1 hypermethylation versus MLH1 "Lynch-like" mismatch repair gene mutation
Michael D Toboni, Sharon Wu, Alex Farrell, et al.
Gynecologic Oncology
|
May 25, 2021
Uterine carcinosarcomas: From pathology to practice
Michael D Toboni, Erin K Crane, Jubilee Brown, et al.
Gynecologic Oncology
|
April 1, 2023
HER2+ endometrioid endometrial cancer possesses distinct molecular and immunologic features associated with a more active immune microenvironment and worse prognosis
Shaina F Bruce, Sharon Wu, Jennifer R Ribeiro, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
June 13, 2020
Long-term outcomes of intensity-modulated radiation therapy (IMRT) and high dose rate brachytherapy as adjuvant therapy after radical hysterectomy for cervical cancer
Jessika Contreras, Amar Srivastava, Anupama Chundury, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
April 14, 2025
Accuracy of surveillance serum squamous cell carcinoma antigen for cervical cancer recurrence after definitive chemoradiation
Victoria Shi, Surbhi Grover, Yi Huang, et al.
Obstetrics and Gynecology
|
March 15, 2019
Wound Complication Rates After Vulvar Excisions for Premalignant Lesions
Mary M Mullen, Emily C Merfeld, Marguerite L Palisoul, et al.
Gynecologic Oncology
|
September 5, 2012
A phase I study with an expanded cohort to assess feasibility of intravenous docetaxel, intraperitoneal carboplatin and intraperitoneal paclitaxel in patients with previously untreated ovarian, fallopian tube or primary peritoneal carcinoma: a Gynecologic Oncology Group study
Natalie Gould, Michael W Sill, Robert S Mannel, et al.
Brain, Behavior, and Immunity
|
February 16, 2023
Propranolol reduces IFN-γ driven PD-L1 immunosuppression and improves anti-tumour immunity in ovarian cancer
M Falcinelli, G Al-Hity, S Baron, et al.
Gynecologic Oncology
|
June 22, 2014
A phase II trial of a surgical protocol to decrease the incidence of wound complications in obese gynecologic oncology patients
Akiva P Novetsky, Israel Zighelboim, Saketh R Guntupalli, et al.
Gynecologic Oncology Reports
|
August 31, 2019
Patients with endometrial cancer continue to lack understanding of their risks for cancer
Subhjit Sekhon, L Stewart Massad, Andrea R Hagemann, et al.
Page
of 24